Results 171 to 180 of about 50,787 (316)

Neurofilament Light Protein: a marker for injury severity, clinical course and outcome following moderate-severe Traumatic Brain Injury [PDF]

Spyridoula Tsetsou, Leah E. McQuillan, David J. Barton, John B. Williamson, Damon G. Lamb, Firas Kobeissy, Guangzheng Cai, Richard Rubenstein, Kevin Wang, Claudia S. Robertson, Amy K. Wagner   +10 more
openalex   +1 more source

WONOEP XVII appraisal: The immunopathogenesis of epilepsy

Epilepsia, EarlyView.
Abstract There is a wealth of data indicating that the immune system plays an important role in seizure disorders. This includes autoimmune encephalitis, in which an immune response directed against neuronal antigens results in brain inflammation and subsequent seizure activity, as well as autoimmune‐associated epilepsy and neuroinflammatory changes ...
Nihan Çarçak, Said Al Maawal, Peravina Thergarajan, Tracie H. L. Tan, Vinod Kumar Mehta, Tamara Baker, David C. Henshall, Aristea S. Galanopoulou, Özlem Akman, Pablo M. Casillas‐Espinosa, Raman Sankar, Laura Librizzi, Adam E. Handel   +12 more
wiley   +1 more source

Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders. [PDF]

Brain Res Bull, 2016
Yuan A, Nixon RA.
europepmc   +1 more source

3′UTR variants of ALS‐linked RNAs modify subcellular and cellular phenotypes

The FEBS Journal, EarlyView.
Our study demonstrates that alternative 3′UTR variants of ALS‐linked transcripts modulate subcellular RNA localization and cytoskeletal architecture. NEFH 3′UTR‐Long promotes nuclear RNA clustering, while SOD1 3′UTR‐Long reduces filopodia formation. These results suggest that 3′UTRs, independent of coding sequences, can influence neuronal phenotypes ...
Melis Savasan‐Sogut, Danae Campos‐Melo, Michael J. Strong   +2 more
wiley   +1 more source

RB1 inactivation in cutaneous carcinomas

Histopathology, EarlyView.
Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.
Tiffany Liv, Antoine Touzé, David Schrama, Serge Guyétant, Mahtab Samimi, Michael T Tetzlaff, Benjamin A Wood, Paul W Harms, Thibault Kervarrec   +8 more
wiley   +1 more source

Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases [PDF]

Domenico Plantone, Angela Stufano, Delia Righi, Sara Locci, Ivo Iavicoli, Piero Lovreglio, Nicola De Stefano   +6 more
openalex   +1 more source

Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks

Journal of Child Psychology and Psychiatry, EarlyView.
Background Anorexia nervosa (AN) is a severe eating disorder associated with drastic reductions in gray and white matter (WM) volume and structural connectivity alterations. However, the hypotheses regarding underlying mechanisms are inconclusive. The current study investigated the relationships of WM volume as well as WM network architecture with ...
Inger Hellerhoff, Daniel Geisler, Fabio Bernardoni, Arne Doose, Friederike I. Tam, David M. Poitz, Nina Chotjewitz, Veit Roessner, Katja Akgün, Tjalf Ziemssen, Stefan Ehrlich   +10 more
wiley   +1 more source

AB1506 PLASMA NEUROFILAMENT LIGHT CHAIN AND GLIAL FIBRILLARY ACIDIC PROTEIN AS BIOMARKERS IN PATIENTS WITH OCULAR SARCOIDOSIS AND NEUROSARCOIDOSIS [PDF]

, 2023
Keld‐Erik Byg, Jakob Grauslund, T. Ellingsen, Jimmi Wied, Lasse Jørgensen Cehofski, Jonna Skov Madsen, Douglas P. Olsen, Helle Hvilsted Nielsen, Tobias Sejbæk   +8 more
openalex   +1 more source

Combinatorial targeting of MYC/BCL2‐associated vulnerabilities in high‐grade B‐cell lymphoma

British Journal of Haematology, EarlyView.
Giulio Donati, Paola Nicoli, Federica Miele, Paola Podini, Giorgia Dina, Angelo Quattrini, Bruno Amati   +6 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source